These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14632929)

  • 1. Development and characterization of potent and specific peptide inhibitors of p60c-src protein tyrosine kinase using pseudosubstrate-based inhibitor design approach.
    Kamath JR; Liu R; Enstrom AM; Lou Q; Lam KS
    J Pept Res; 2003 Dec; 62(6):260-8. PubMed ID: 14632929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
    Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
    J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent pseudosubstrate-based peptide inhibitors for p60(c-src) protein tyrosine kinase.
    Lou Q; Leftwich ME; McKay RT; Salmon SE; Rychetsky L; Lam KS
    Cancer Res; 1997 May; 57(10):1877-81. PubMed ID: 9157979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of efficient pentapeptide substrates for the tyrosine kinase pp60c-src.
    Nair SA; Kim MH; Warren SD; Choi S; Songyang Z; Cantley LC; Hangauer DG
    J Med Chem; 1995 Oct; 38(21):4276-83. PubMed ID: 7473555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a novel synthetic peptide substrate specific for Src-family protein tyrosine kinases.
    Lam KS; Wu J; Lou Q
    Int J Pept Protein Res; 1995 Jun; 45(6):587-92. PubMed ID: 7558590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of GIYWHHY as a novel peptide substrate for human p60c-src protein tyrosine kinase.
    Lou Q; Leftwich ME; Lam KS
    Bioorg Med Chem; 1996 May; 4(5):677-82. PubMed ID: 8804533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of indole esters as inhibitors of p60(c-Src) receptor tyrosine kinase and investigation of the inhibition using receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    J Enzyme Inhib Med Chem; 2003 Dec; 18(6):485-90. PubMed ID: 15008512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-myristoylation of a peptide substrate for Src converts it into an apparent slow-binding bisubstrate-type inhibitor.
    Ramdas L; Obeyesekere NU; Sun G; McMurray JS; Budde RJ
    J Pept Res; 1999 May; 53(5):569-77. PubMed ID: 10424353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reusable amperometric biosensor for measuring protein tyrosine kinase activity.
    Wang CL; Wei LY; Yuan CJ; Hwang KC
    Anal Chem; 2012 Jan; 84(2):971-7. PubMed ID: 22208917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    Farmaco; 2005; 60(6-7):497-506. PubMed ID: 15927182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tight-binding inhibitory sequences against pp60(c-src) identified using a random 15-amino-acid peptide library.
    Nishi T; Budde RJ; McMurray JS; Obeyesekere NU; Safdar N; Levin VA; Saya H
    FEBS Lett; 1996 Dec; 399(3):237-40. PubMed ID: 8985153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60(c-src) kinase activity.
    Wijetunge S; Lymn JS; Hughes AD
    Br J Pharmacol; 2000 Apr; 129(7):1347-54. PubMed ID: 10742290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles.
    Boschelli DH; Wu B; Ye F; Wang Y; Golas JM; Lucas J; Boschelli F
    J Med Chem; 2006 Dec; 49(26):7868-76. PubMed ID: 17181170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain:phosphotyrosine mimetics exploiting multifunctional group replacement chemistry.
    Sundaramoorthi R; Kawahata N; Yang MG; Shakespeare WC; Metcalf CA; Wang Y; Merry T; Eyermann CJ; Bohacek RS; Narula S; Dalgarno DC; Sawyer TK
    Biopolymers; 2003; 71(6):717-29. PubMed ID: 14991680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src.
    Nada S; Okada M; MacAuley A; Cooper JA; Nakagawa H
    Nature; 1991 May; 351(6321):69-72. PubMed ID: 1709258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
    Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
    Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c-)(src).
    Wang W; Ramdas L; Sun G; Ke S; Obeyesekere NU; Budde RJ; McMurray JS
    Biochemistry; 2000 May; 39(17):5221-8. PubMed ID: 10819990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural determinants for potent, selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines.
    Tian G; Cory M; Smith AA; Knight WB
    Biochemistry; 2001 Jun; 40(24):7084-91. PubMed ID: 11401553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors.
    Kumar A; Ye G; Wang Y; Lin X; Sun G; Parang K
    J Med Chem; 2006 Jun; 49(11):3395-401. PubMed ID: 16722659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.